Advanced search

Vol 57, No 2 (2019)
Review paper
Published online: 2019-05-16

open access

View PDF Download PDF file
Page views 2708
Article views/downloads 1306
Get Citation

Connect on Social Media

Connect on Social Media

MPP1-based mechanism of resting state raft organization in the plasma membrane. Is it a general or specialized mechanism in erythroid cells?

Magdalena Trybus1, Lukasz Niemiec1, Agnieszka Biernatowska1, Anita Hryniewicz-Jankowska1, Aleksander F. Sikorski1
DOI: 10.5603/FHC.a2019.0007
Pubmed: 31099889
Folia Histochem Cytobiol 2019;57(2):43-55.

Abstract

Biological membranes are organized in various microdomains, one of the best known being called membrane rafts. The major function of these is thought to organize signaling partners into functional complexes. An important protein found in membrane raft microdomains of erythroid and other blood cells is MPP1 (membrane palmitoylated protein 1)/p55. MPP1 (p55) belongs to the MAGUK (membrane-associated guanylate kinase homolog) family and it is a major target of palmitoylation in the red blood cells (RBCs) membrane. The well-known function of this protein is to participate in formation of the junctional complex of the erythrocyte mem­brane skeleton. However, its function as a “raft organizer” is not well understood. In this review we focus on recent reports concerning MPP1 participation in membrane rafts organization in erythroid cells, including its role in signal transduction. Currently it is not known whether MPP1 could have a similar role in cell types other than erythroid lineage. We present also preliminary data regarding the expression level of MPP1 gene in several non-erythroid cell lines.

Keywords: membrane palmitoylated protein 1 (MPP1)resting state raftslateral membrane organizationraft-associated proteins

Article available in PDF format

View PDF Download PDF file

References

  1. Machnicka B, Czogalla A, Hryniewicz-Jankowska A, et al. Spectrins: a structural platform for stabilization and activation of membrane channels, receptors and transporters. Biochim Biophys Acta. 2014; 1838(2): 620–634.
    CrossRefPubMed
  2. Machnicka B, Grochowalska R, Bogusławska DM, et al. Spectrin-based skeleton as an actor in cell signaling. Cell Mol Life Sci. 2012; 69(2): 191–201.
    CrossRefPubMed
  3. Lux SE. Anatomy of the red cell membrane skeleton: unanswered questions. Blood. 2016; 127(2): 187-199. .
    CrossRefPubMed
  4. Sikorski AF, Podkalicka J, Jones W, et al. Membrane rafts in the erythrocyte membrane: a novel role of MPP1p55. Adv Exp Med Biol. 2015; 842: 61–78.
    CrossRefPubMed
  5. Koshino I, Takakuwa Y. Disruption of lipid rafts by lidocaine inhibits erythrocyte invasion by Plasmodium falciparum. Exp Parasitol. 2009; 123(4): 381–383.
    CrossRefPubMed
  6. Kamata K, Manno S, Ozaki M, et al. Functional evidence for presence of lipid rafts in erythrocyte membranes: Gsalpha in rafts is essential for signal transduction. Am J Hematol. 2008; 83(5): 371–375.
    CrossRefPubMed
  7. Hashimoto M, Hossain S, Katakura M, et al. The binding of Aβ1-42 to lipid rafts of RBC is enhanced by dietary docosahexaenoic acid in rats: Implicates to Alzheimer's disease. Biochim Biophys Acta. 2015; 1848(6): 1402–1409.
    CrossRefPubMed
  8. Leonard C, Conrard L, Guthmann M, et al. Contribution of plasma membrane lipid domains to red blood cell (re) shaping. Sci Rep. 2017; 7(1): 4264.
    CrossRef
  9. Simons K, Ikonen E. Functional rafts in cell membranes. Nature. 1997; 387(6633): 569–572.
    CrossRefPubMed
  10. Raghunathan K, Kenworthy AK. Dynamic pattern generation in cell membranes: Current insights into membrane organization. Biochim Biophys Acta Biomembr. 2018; 1860(10): 2018–2031.
    CrossRefPubMed
  11. Bieberich E. Sphingolipids and lipid rafts: Novel concepts and methods of analysis. Chem Phys Lipids. 2018; 216: 114–131.
    CrossRefPubMed
  12. Kinoshita M, Suzuki KGN, Murata M, et al. Evidence of lipid rafts based on the partition and dynamic behavior of sphingomyelins. Chem Phys Lipids. 2018; 215: 84–95.
    CrossRefPubMed
  13. Rawat SS, Zimmerman C, Johnson BT, et al. Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion. Mol Membr Biol. 2008; 25(1): 83–94.
    CrossRefPubMed
  14. Pucadyil TJ, Chattopadhyay A. Effect of cholesterol on lateral diffusion of fluorescent lipid probes in native hippocampal membranes. Chem Phys Lipids. 2006; 143(1-2): 11–21.
    CrossRefPubMed
  15. Simons K, Vaz WLC. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct. 2004; 33: 269–295.
    CrossRefPubMed
  16. Lingwood D, Simons K. Detergent resistance as a tool in membrane research. Nat Protoc. 2007; 2(9): 2159–2165.
    CrossRefPubMed
  17. Lichtenberg D, Goñi FM, Heerklotz H. Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem Sci. 2005; 30(8): 430–436.
    CrossRefPubMed
  18. Pike LJ, Han X, Gross RW. Epidermal Growth Factor Receptors Are Localized to Lipid Rafts. J Biol Chem 2005;280(29): 26796-26804 . .
    CrossRefPubMed
  19. Grzybek M, Kubiak J, Łach A, et al. A raft-associated species of phosphatidylethanolamine interacts with cholesterol comparably to sphingomyelin. A Langmuir-Blodgett monolayer study. PLoS One. 2009; 4(3): e5053.
    CrossRefPubMed
  20. Brown DA, London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem. 2000; 275(23): 17221–17224.
    CrossRefPubMed
  21. Browman DT, Hoegg MB, Robbins SM. The SPFH domain-containing proteins: more than lipid raft markers. Trends Cell Biol. 2007; 17(8): 394–402.
    CrossRefPubMed
  22. Wang TY, Leventis R, Silvius JR. Fluorescence-based evaluation of the partitioning of lipids and lipidated peptides into liquid-ordered lipid microdomains: a model for molecular partitioning into. Biophys J. 2000; 79(2): 919–933.
    CrossRefPubMed
  23. Fantini J, Barrantes FJ. How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains. Front Physiol. 2013; 4: 31.
    CrossRefPubMed
  24. Mahfoud R, Garmy N, Maresca M, et al. Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins. J Biol Chem. 2002; 277(13): 11292–11296.
    CrossRefPubMed
  25. Boggon TJ, Eck MJ. Structure and regulation of Src family kinases. Oncogene. 2004; 23(48): 7918–7927.
    CrossRefPubMed
  26. Pike L. Lipid rafts. Journal of Lipid Research. 2003; 44(4): 655–667.
    CrossRef
  27. Aydar E, Palmer CP, Djamgoz MBA. Sigma receptors and cancer: possible involvement of ion channels. Cancer Res. 2004; 64(15): 5029–5035.
    CrossRefPubMed
  28. Hryniewicz-Jankowska A, Augoff K, Biernatowska A, et al. Membrane rafts as a novel target in cancer therapy. Biochim Biophys Acta. 2014; 1845(2): 155–165.
    CrossRefPubMed
  29. Staubach S, Hanisch FG. Lipid rafts: signaling and sorting platforms of cells and their roles in cancer. Expert Rev Proteomics. 2011; 8(2): 263–277.
    CrossRefPubMed
  30. Field KA, Holowka D, Baird B. Fc epsilon RI-mediated recruitment of p53/56lyn to detergent-resistant membrane domains accompanies cellular signaling. Proc Natl Acad Sci U S A. 1995; 92(20): 9201–9205.
    CrossRefPubMed
  31. Varshney P, Yadav V, Saini N. Lipid rafts in immune signalling: current progress and future perspective. Immunology. 2016; 149(1): 13–24.
    CrossRefPubMed
  32. Dick RA, Goh SL, Feigenson GW, et al. HIV-1 Gag protein can sense the cholesterol and acyl chain environment in model membranes. Proc Natl Acad Sci U S A. 2012; 109(46): 18761–18766.
    CrossRefPubMed
  33. Chinnapen DJF, Chinnapen H, Saslowsky D, et al. Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. FEMS Microbiol Lett. 2007; 266(2): 129–137.
    CrossRefPubMed
  34. Sandvig K, Bergan J, Kavaliauskiene S, et al. Lipid requirements for entry of protein toxins into cells. Prog Lipid Res. 2014; 54: 1–13.
    CrossRefPubMed
  35. Raghunathan K, Foegeding NJ, Campbell AM, et al. Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA. Infect Immun. 2018; 86(5).
    CrossRefPubMed
  36. Morey P, Pfannkuch L, Pang E, et al. Helicobacter pylori Depletes Cholesterol in Gastric Glands to Prevent Interferon Gamma Signaling and Escape the Inflammatory Response. Gastroenterology. 2018; 154(5): 1391–1404.e9.
    CrossRefPubMed
  37. Rios FJO, Ferracini M, Pecenin M, et al. Uptake of oxLDL and IL-10 production by macrophages requires PAFR and CD36 recruitment into the same lipid rafts. PLoS One. 2013; 8(10): e76893.
    CrossRefPubMed
  38. Rios FJ, Koga MM, Pecenin M, et al. Oxidized LDL induces alternative macrophage phenotype through activation of CD36 and PAFR. Mediators Inflamm. 2013; 2013: 198193.
    CrossRefPubMed
  39. Kaul S, Xu H, Zabalawi M, et al. Lipid-Free Apolipoprotein A-I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio. J Am Heart Assoc. 2016; 5(11).
    CrossRefPubMed
  40. Huang SS, Liu IH, Chen CL, et al. 7-Dehydrocholesterol (7-DHC), But Not Cholesterol, Causes Suppression of Canonical TGF-β Signaling and Is Likely Involved in the Development of Atherosclerotic Cardiovascular Disease (ASCVD). J Cell Biochem. 2017; 118(6): 1387–1400.
    CrossRefPubMed
  41. Hancock JF. Lipid rafts: contentious only from simplistic standpoints. Nat Rev Mol Cell Biol. 2006; 7(6): 456–462.
    CrossRefPubMed
  42. Simons K, Gerl MJ. Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol. 2010; 11(10): 688–699.
    CrossRefPubMed
  43. Pike LJ. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res. 2006; 47(7): 1597–1598.
    CrossRefPubMed
  44. Sezgin E, Levental I, Mayor S, et al. The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol. 2017; 18(6): 361–374.
    CrossRefPubMed
  45. Sevcsik E, Schütz GJ. With or without rafts? Alternative views on cell membranes. Bioessays. 2016; 38(2): 129–139.
    CrossRefPubMed
  46. Ramstedt B, Slotte JP. Interaction of cholesterol with sphingomyelins and acyl-chain-matched phosphatidylcholines: a comparative study of the effect of the chain length. Biophys J. 1999; 76(2): 908–915.
    CrossRefPubMed
  47. Lozano MM, Hovis JS, Moss FR, et al. Dynamic Reorganization and Correlation among Lipid Raft Components. J Am Chem Soc. 2016; 138(31): 9996–10001.
    CrossRefPubMed
  48. Schwarzer R, Levental I, Gramatica A, et al. The cholesterol-binding motif of the HIV-1 glycoprotein gp41 regulates lateral sorting and oligomerization. Cell Microbiol. 2014; 16(10): 1565–1581.
    CrossRefPubMed
  49. Tulodziecka K, Diaz-Rohrer BB, Farley MM, et al. Remodeling of the postsynaptic plasma membrane during neural development. Mol Biol Cell. 2016; 27(22): 3480–3489.
    CrossRefPubMed
  50. Contreras FX, Ernst AM, Haberkant P, et al. Molecular recognition of a single sphingolipid species by a protein's transmembrane domain. Nature. 2012; 481(7382): 525–529.
    CrossRefPubMed
  51. Dalton G, An SW, Al-Juboori SI, et al. Soluble klotho binds monosialoganglioside to regulate membrane microdomains and growth factor signaling. Proc Natl Acad Sci U S A. 2017; 114(4): 752–757.
    CrossRefPubMed
  52. Pitre A, Ge Y, Lin W, et al. An unexpected protein interaction promotes drug resistance in leukemia. Nat Commun. 2017; 8(1): 1547.
    CrossRefPubMed
  53. Killian JA, von Heijne G. How proteins adapt to a membrane-water interface. Trends Biochem Sci. 2000; 25(9): 429–434.
    CrossRefPubMed
  54. Köster DV, Mayor S. Cortical actin and the plasma membrane: inextricably intertwined. Curr Opin Cell Biol. 2016; 38: 81–89.
    CrossRefPubMed
  55. Marguet D, Lenne PF, Rigneault H, et al. Dynamics in the plasma membrane: how to combine fluidity and order. EMBO J. 2006; 25(15): 3446–3457.
    CrossRefPubMed
  56. Honigmann A, Sadeghi S, Keller J, et al. A lipid bound actin meshwork organizes liquid phase separation in model membranes. Elife. 2014; 3: e01671.
    CrossRefPubMed
  57. Ehrig J, Petrov EP, Schwille P. Near-critical fluctuations and cytoskeleton-assisted phase separation lead to subdiffusion in cell membranes. Biophys J. 2011; 100(1): 80–89.
    CrossRefPubMed
  58. Levental I, Grzybek M, Simons K. Raft domains of variable properties and compositions in plasma membrane vesicles. Proc Natl Acad Sci U S A. 2011; 108(28): 11411–11416.
    CrossRefPubMed
  59. Baumgart T, Hammond AT, Sengupta P, et al. Large-scale fluid/fluid phase separation of proteins and lipids in giant plasma membrane vesicles. Proc Natl Acad Sci U S A. 2007; 104(9): 3165–3170.
    CrossRefPubMed
  60. Sezgin E, Kaiser HJ, Baumgart T, et al. Elucidating membrane structure and protein behavior using giant plasma membrane vesicles. Nat Protoc. 2012; 7(6): 1042–1051.
    CrossRefPubMed
  61. Biernatowska A, Podkalicka J, Majkowski M, et al. The role of MPP1/p55 and its palmitoylation in resting state raft organization in HEL cells. Biochim Biophys Acta. 2013; 1833(8): 1876–1884.
    CrossRefPubMed
  62. Dimitratos SD, Woods DF, Stathakis DG, et al. Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family. Bioessays. 1999; 21(11): 912–921, doi: 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z.
    PubMed
  63. Anderson JM. Cell signalling: MAGUK magic. Curr Biol. 1996; 6(4): 382–384.
    PubMed
  64. Ruff P, Speicher DW, Husain-Chishti A. Molecular identification of a major palmitoylated erythrocyte membrane protein containing the src homology 3 motif. Proc Natl Acad Sci U S A. 1991; 88(15): 6595–6599.
    CrossRefPubMed
  65. Seo PS, Quinn BJ, Khan AA, et al. Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin. Exp Biol Med (Maywood). 2009; 234(3): 255–262.
    CrossRefPubMed
  66. Marfatia SM, Morais-Cabral JH, Kim AC, et al. The PDZ domain of human erythrocyte p55 mediates its binding to the cytoplasmic carboxyl terminus of glycophorin C. Analysis of the binding interface by in vitro mutagenesis. J Biol Chem. 1997; 272(39): 24191–24197.
    CrossRefPubMed
  67. Hemming NJ, Anstee DJ, Staricoff MA, et al. Identification of the membrane attachment sites for protein 4.1 in the human erythrocyte. J Biol Chem. 1995; 270(10): 5360–5366.
    CrossRefPubMed
  68. Podkalicka J, Biernatowska A, Majkowski M, et al. MPP1 as a Factor Regulating Phase Separation in Giant Plasma Membrane-Derived Vesicles. Biophys J. 2015; 108(9): 2201–2211.
    CrossRefPubMed
  69. Levental I, Lingwood D, Grzybek M, et al. Palmitoylation regulates raft affinity for the majority of integral raft proteins. Proc Natl Acad Sci U S A. 2010; 107(51): 22050–22054.
    CrossRefPubMed
  70. Podkalicka J, Biernatowska A, Olszewska P, et al. The microdomain-organizing protein MPP1 is required for insulin-stimulated activation of H-Ras. Oncotarget. 2018; 9(26): 18410–18421.
    CrossRefPubMed
  71. Chishti AH. Function of p55 and its nonerythroid homologues. Curr Opin Hematol. 1998; 5(2): 116–121.
    PubMed
  72. Marfatia SM, Lue RA, Branton D, et al. In vitro binding studies suggest a membrane-associated complex between erythroid p55, protein 4.1, and glycophorin C. J Biol Chem. 1994; 269(12): 8631–8634.
    PubMed
  73. Diakowski W, Grzybek M, Sikorski AF. Protein 4.1, a component of the erythrocyte membrane skeleton and its related homologue proteins forming the protein 4.1/FERM superfamily. Folia Histochem Cytobiol. 2006; 44(4): 231–248.
    PubMed
  74. Ward RE, Schweizer L, Lamb RS, et al. The protein 4.1, ezrin, radixin, moesin (FERM) domain of Drosophila Coracle, a cytoplasmic component of the septate junction, provides functions essential for embryonic development and imaginal cell proliferation. Genetics. 2001; 159(1): 219–228.
    PubMed
  75. Biernatowska A, Augoff K, Podkalicka J, et al. MPP1 directly interacts with flotillins in erythrocyte membrane - Possible mechanism of raft domain formation. Biochim Biophys Acta Biomembr. 2017; 1859(11): 2203–2212.
    CrossRefPubMed
  76. Lang DM, Lommel S, Jung M, et al. Identification of reggie-1 and reggie-2 as plasmamembrane-associated proteins which cocluster with activated GPI-anchored cell adhesion molecules in non-caveolar micropatches in neurons. J Neurobiol. 1998; 37(4): 502–523.
    PubMed
  77. Neumann-Giesen C, Fernow I, Amaddii M, et al. Role of EGF-induced tyrosine phosphorylation of reggie-1/flotillin-2 in cell spreading and signaling to the actin cytoskeleton. J Cell Sci. 2007; 120(Pt 3): 395–406.
    CrossRefPubMed
  78. Amaddii M, Meister M, Banning A, et al. Flotillin-1/reggie-2 protein plays dual role in activation of receptor-tyrosine kinase/mitogen-activated protein kinase signaling. J Biol Chem. 2012; 287(10): 7265–7278.
    CrossRefPubMed
  79. Ludwig A, Otto GP, Riento K, et al. Flotillin microdomains interact with the cortical cytoskeleton to control uropod formation and neutrophil recruitment. J Cell Biol. 2010; 191(4): 771–781.
    CrossRefPubMed
  80. Nakamura H, Sudo T, Tsuiki H, et al. Identification of a novel human homolog of the Drosophila dlg, P-dlg, specifically expressed in the gland tissues and interacting with p55. FEBS Lett. 1998; 433(1-2): 63–67.
    PubMed
  81. Mburu P, Kikkawa Y, Townsend S, et al. Whirlin complexes with p55 at the stereocilia tip during hair cell development. Proc Natl Acad Sci U S A. 2006; 103(29): 10973–10978.
    CrossRefPubMed
  82. Quinn BJ, Welch EJ, Kim AC, et al. Erythrocyte scaffolding protein p55/MPP1 functions as an essential regulator of neutrophil polarity. Proc Natl Acad Sci U S A. 2009; 106(47): 19842–19847.
    CrossRefPubMed
  83. Evans DG. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis. 2009; 4: 16.
    CrossRefPubMed
  84. Listowski MA, Leluk J, Kraszewski S, et al. Cholesterol Interaction with the MAGUK Protein Family Member, MPP1, via CRAC and CRAC-Like Motifs: An In Silico Docking Analysis. PLoS One. 2015; 10(7): e0133141.
    CrossRefPubMed
  85. Elderdfi M, Zegarlińska J, Jones W, et al. MPP1 interacts with DOPC/SM/Cholesterol in an artificial membrane system using Langmuir-Blodgett monolayer. Gen Physiol Biophys. 2017; 36(4): 443–454.
    CrossRefPubMed
  86. Elderdfi M, Sikorski AF. Interaction of membrane palmitoylated protein-1 with model lipid membranes. Gen Physiol Biophys. 2018; 37(6): 603–617.
    CrossRefPubMed
  87. Sharma P, Varma R, Sarasij RC, et al. Nanoscale organization of multiple GPI-anchored proteins in living cell membranes. Cell. 2004; 116(4): 577–589.
    CrossRefPubMed
  88. Mayor S, Rao M. Rafts: scale-dependent, active lipid organization at the cell surface. Traffic. 2004; 5(4): 231–240.
    CrossRefPubMed
  89. Fujita M, Kinoshita T. Structural remodeling of GPI anchors during biosynthesis and after attachment to proteins. FEBS Lett. 2010; 584(9): 1670–1677.
    CrossRefPubMed
  90. Eggeling C, Ringemann C, Medda R, et al. Direct observation of the nanoscale dynamics of membrane lipids in a living cell. Nature. 2009; 457(7233): 1159–1162.
    CrossRefPubMed
  91. Navarro-Lérida I, Sánchez-Perales S, Calvo M, et al. A palmitoylation switch mechanism regulates Rac1 function and membrane organization. EMBO J. 2012; 31(3): 534–551.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023-2024 Via Medica Regulations Cookie policy Privacy Statement Legal Note